EP1615698B1
(en)
*
|
2003-04-11 |
2010-09-29 |
High Point Pharmaceuticals, LLC |
New amide derivatives and pharmaceutical use thereof
|
CN1822820A
(zh)
*
|
2003-07-28 |
2006-08-23 |
雷迪实验室有限公司 |
心血管疾病的治疗和预防
|
EP2036548A1
(en)
|
2003-09-22 |
2009-03-18 |
onepharm Research & Development GmbH |
Prevention and treatment of inflammation-induced and/or immune-mediated bone loss
|
KR101135885B1
(ko)
|
2004-01-09 |
2012-04-16 |
코어셉트 쎄라퓨틱스, 잉크. |
아자데칼린 글루코코르티코이드 수용체 조절제
|
US20100222316A1
(en)
|
2004-04-29 |
2010-09-02 |
Abbott Laboratories |
Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
|
US8415354B2
(en)
|
2004-04-29 |
2013-04-09 |
Abbott Laboratories |
Methods of use of inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
|
US7880001B2
(en)
|
2004-04-29 |
2011-02-01 |
Abbott Laboratories |
Inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme
|
JP5014983B2
(ja)
|
2004-05-07 |
2012-08-29 |
ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ |
11−ベータヒドロキシステロイドデヒドロゲナーゼ阻害剤としてのピロリジン−2−オン及びピペリジン−2−オン誘導体
|
TWI350168B
(en)
|
2004-05-07 |
2011-10-11 |
Incyte Corp |
Amido compounds and their use as pharmaceuticals
|
EP1753512B1
(en)
|
2004-05-28 |
2008-07-09 |
Nycomed GmbH |
Tetrahydropyridothiophenes
|
CA2569623A1
(en)
|
2004-06-11 |
2005-12-22 |
Altana Pharma Ag |
Novel compounds and use of tetrahydropyridothiophenes
|
BRPI0512535A
(pt)
|
2004-06-24 |
2008-03-25 |
Incyte Corp |
compostos de piperidinas n-substituìdas, suas composições e métodos de modulações
|
US7618980B2
(en)
|
2004-07-14 |
2009-11-17 |
Bristol-Myers Squibb Company |
Pyrrolo(oxo)quinolines as 5HT ligands
|
US7572805B2
(en)
|
2004-07-14 |
2009-08-11 |
Bristol-Myers Squibb Company |
Pyrrolo(oxo)isoquinolines as 5HT ligands
|
DE602005017159D1
(de)
|
2004-08-30 |
2009-11-26 |
Janssen Pharmaceutica Nv |
Oxysteroid-dehydrogenase-inhibitoren
|
NZ553159A
(en)
|
2004-08-30 |
2010-05-28 |
Janssen Pharmaceutica Nv |
N-Adamantan-2-yl-2-phenoxy-acetamide derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors
|
EP1786774B1
(en)
*
|
2004-08-30 |
2009-10-14 |
Janssen Pharmaceutica N.V. |
Tricyclic lactam derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors
|
AU2005291561B2
(en)
*
|
2004-10-04 |
2010-02-25 |
F. Hoffmann-La Roche Ag |
Alkil-pyridines as 11-beta inhibitors for diabetes
|
US8110581B2
(en)
|
2004-11-10 |
2012-02-07 |
Incyte Corporation |
Lactam compounds and their use as pharmaceuticals
|
CN102816081A
(zh)
|
2005-01-05 |
2012-12-12 |
雅培制药有限公司 |
11-β-羟甾类脱氢酶1型酶的抑制剂
|
US20090192198A1
(en)
|
2005-01-05 |
2009-07-30 |
Abbott Laboratories |
Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
|
EP1846363B1
(en)
|
2005-01-05 |
2012-04-25 |
Abbott Laboratories |
Adamantyl derivatives as inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
|
US8198331B2
(en)
|
2005-01-05 |
2012-06-12 |
Abbott Laboratories |
Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
|
EP1851229A1
(en)
|
2005-02-09 |
2007-11-07 |
Nycomed GmbH |
Tetrahydropyridothiophenes for the treatment of proliferative diseases such as cancer
|
US7741488B2
(en)
|
2005-02-11 |
2010-06-22 |
4Sc Ag |
Tetrahydropyridothiophenes as antiproliferative agents for the treatment of cancer
|
WO2006105127A2
(en)
*
|
2005-03-31 |
2006-10-05 |
Takeda San Diego, Inc. |
Hydroxysteroid dehydrogenase inhibitors
|
PL1928840T3
(pl)
|
2005-04-05 |
2012-01-31 |
Hoffmann La Roche |
1H-pirazolo-4-karboksyamidy, ich wytwarzanie i ich zastosowanie jako inhibitory dehydrogenazy 11-beta-hydroksysteroidowej
|
US20060235028A1
(en)
*
|
2005-04-14 |
2006-10-19 |
Li James J |
Inhibitors of 11-beta hydroxysteroid dehydrogenase type I
|
US7714136B2
(en)
|
2005-05-25 |
2010-05-11 |
4Sc Ag |
Tetrahydropyridothiophenes
|
US7763728B2
(en)
|
2005-05-25 |
2010-07-27 |
4Sc Ag |
Tetrahydropyridothiophenes
|
WO2006132197A1
(ja)
|
2005-06-07 |
2006-12-14 |
Shionogi & Co., Ltd. |
I型11βヒドロキシステロイド脱水素酵素阻害活性を有するヘテロ環化合物
|
US7579360B2
(en)
|
2005-06-09 |
2009-08-25 |
Bristol-Myers Squibb Company |
Triazolopyridine 11-beta hydroxysteroid dehydrogenase type I inhibitors
|
US7572807B2
(en)
*
|
2005-06-09 |
2009-08-11 |
Bristol-Myers Squibb Company |
Heteroaryl 11-beta-hydroxysteroid dehydrogenase type I inhibitors
|
US7605289B2
(en)
|
2005-06-17 |
2009-10-20 |
Amgen, Inc. |
Benzamide derivatives and uses related thereto
|
ATE520670T1
(de)
|
2005-07-05 |
2011-09-15 |
Hoffmann La Roche |
Pyridazinderivate
|
CA2615718A1
(en)
|
2005-07-22 |
2007-02-01 |
Amgen Inc. |
Aniline sulfonamide derivatives and their uses
|
WO2007017728A2
(en)
*
|
2005-08-05 |
2007-02-15 |
Orchid Research Laboratories Limited |
Novel heterocyclic compounds
|
US7622492B2
(en)
|
2005-08-31 |
2009-11-24 |
Hoffmann-La Roche Inc. |
Pyrazolones as inhibitors of 11β-hydroxysteroid dehydrogenase
|
EP1931652A2
(en)
*
|
2005-09-21 |
2008-06-18 |
Incyte Corporation |
Amido compounds and their use as pharmaceuticals
|
GB0521716D0
(en)
*
|
2005-10-25 |
2005-11-30 |
Genomica Sau |
Modulation of 11beta-hydroxysteriod dehydrogenase 1 expression for the treatment of ocular diseases
|
JP2009514818A
(ja)
*
|
2005-11-01 |
2009-04-09 |
ハイ ポイント ファーマシューティカルズ,リミティド ライアビリティ カンパニー |
置換アミドの製薬学的用途
|
US20070116756A1
(en)
*
|
2005-11-23 |
2007-05-24 |
Dr. Reddy's Laboratories Limited |
Stable pharmaceutical compositions
|
KR101415861B1
(ko)
|
2005-12-05 |
2014-07-04 |
인사이트 코포레이션 |
락탐 화합물 및 이를 사용하는 방법
|
EP1801098A1
(en)
|
2005-12-16 |
2007-06-27 |
Merck Sante |
2-Adamantylurea derivatives as selective 11B-HSD1 inhibitors
|
US7998959B2
(en)
|
2006-01-12 |
2011-08-16 |
Incyte Corporation |
Modulators of 11-β hydroxyl steroid dehydrogenase type 1, pharmaceutical compositions thereof, and methods of using the same
|
KR101081293B1
(ko)
|
2006-01-18 |
2011-11-08 |
에프. 호프만-라 로슈 아게 |
11 베타-에이치에스디1 억제제로서 티아졸
|
BRPI0707537A2
(pt)
|
2006-02-07 |
2011-05-03 |
Wyeth Corp |
inibidores de 11-beta hsd1
|
WO2007093507A1
(en)
*
|
2006-02-13 |
2007-08-23 |
F. Hoffmann-La Roche Ag |
Heterobicyclic sulfonamide derivatives for the treatment of diabetes
|
US8017638B2
(en)
|
2006-03-30 |
2011-09-13 |
Shionogi & Co., Ltd. |
Isoxazole derivative and isothiazole derivative having inhibitory activity on 11β-hydroxysteroid dehydrogenase type 1
|
CA2649677A1
(en)
|
2006-05-01 |
2007-11-15 |
Incyte Corporation |
Tetrasubstituted ureas as modulators of 11-.beta. hydroxyl steroid dehydrogenase type 1
|
PE20080251A1
(es)
|
2006-05-04 |
2008-04-25 |
Boehringer Ingelheim Int |
Usos de inhibidores de dpp iv
|
CA2652375A1
(en)
|
2006-05-17 |
2007-11-29 |
Incyte Corporation |
Heterocyclic inhibitors of 11-.beta. hydroxyl steroid dehydrogenase type i and methods of using the same
|
TW200808695A
(en)
*
|
2006-06-08 |
2008-02-16 |
Amgen Inc |
Benzamide derivatives and uses related thereto
|
US7659287B2
(en)
|
2006-06-08 |
2010-02-09 |
Amgen Inc. |
Benzamide derivatives and uses related thereto
|
AU2007271273B2
(en)
*
|
2006-07-05 |
2011-09-01 |
F. Hoffmann-La Roche Ag |
Alkyl-pyridazine derivatives as inhibitors of 11 beta hydroxysteroid dehydrogenase type 1(11B-HSD 1)
|
AU2007283113A1
(en)
|
2006-08-08 |
2008-02-14 |
Sanofi-Aventis |
Arylaminoaryl-alkyl-substituted imidazolidine-2,4-diones, processes for preparing them, medicaments comprising these compounds, and their use
|
US7727978B2
(en)
|
2006-08-24 |
2010-06-01 |
Bristol-Myers Squibb Company |
Cyclic 11-beta hydroxysteroid dehydrogenase type I inhibitors
|
TW200827346A
(en)
|
2006-11-03 |
2008-07-01 |
Astrazeneca Ab |
Chemical compounds
|
DE102006058207A1
(de)
*
|
2006-12-11 |
2008-06-19 |
Universitätsklinikum Schleswig-Holstein |
Verfahren zur Herstellung spezifischer Inhibitoren der 11beta-Hydroxysteroid-Dehydrogenase Typ 1 mit Nor-Oleanan- oder Nor-Ursan-Grundgerüsten
|
EP1935420A1
(en)
|
2006-12-21 |
2008-06-25 |
Merck Sante |
2-Adamantyl-butyramide derivatives as selective 11beta-HSD1 inhibitors
|
CA2674237C
(en)
*
|
2006-12-28 |
2015-11-24 |
Rigel Pharmaceuticals, Inc. |
N-substituted-heterocycloalkyloxybenzamide compounds and methods of use
|
DE102007005045B4
(de)
|
2007-01-26 |
2008-12-18 |
Sanofi-Aventis |
Phenothiazin Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
TW200836719A
(en)
|
2007-02-12 |
2008-09-16 |
Astrazeneca Ab |
Chemical compounds
|
AU2008219326B2
(en)
*
|
2007-02-23 |
2012-12-13 |
Vtv Therapeutics Llc |
N-adamantyl benzamides as inhibitors of 11-beta-hydroxysteroid dehydrogenase
|
DK2124562T3
(en)
|
2007-03-09 |
2016-08-01 |
Second Genome Inc |
BICYCLOHETEROARYLFORBINDELSER AS P2X7 modulators and uses thereof
|
CL2008001839A1
(es)
|
2007-06-21 |
2009-01-16 |
Incyte Holdings Corp |
Compuestos derivados de 2,7-diazaespirociclos, inhibidores de 11-beta hidroxil esteroide deshidrogenasa tipo 1; composicion farmaceutica que comprende a dichos compuestos; utiles para tratar la obesidad, diabetes, intolerancia a la glucosa, diabetes tipo ii, entre otras enfermedades.
|
JP2009035513A
(ja)
*
|
2007-08-02 |
2009-02-19 |
Ube Ind Ltd |
4−n−(メチルベンゾイル)アミノ−2−メチル安息香酸の製法
|
EP2025674A1
(de)
|
2007-08-15 |
2009-02-18 |
sanofi-aventis |
Substituierte Tetrahydronaphthaline, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
JP5736098B2
(ja)
|
2007-08-21 |
2015-06-17 |
アッヴィ・インコーポレイテッド |
中枢神経系障害を治療するための医薬組成物
|
US8119658B2
(en)
|
2007-10-01 |
2012-02-21 |
Bristol-Myers Squibb Company |
Triazolopyridine 11-beta hydroxysteroid dehydrogenase type I inhibitors
|
US8304539B2
(en)
*
|
2008-02-07 |
2012-11-06 |
Bristol-Myers Squibb Company |
Fused heteroaryl modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof
|
JP5658138B2
(ja)
|
2008-04-23 |
2015-01-21 |
ライジェル ファーマシューティカルズ, インコーポレイテッド |
代謝障害の処置のためのカルボキサミド化合物
|
UY31968A
(es)
|
2008-07-09 |
2010-01-29 |
Sanofi Aventis |
Nuevos derivados heterocíclicos, sus procesos para su preparación, y sus usos terapéuticos
|
GB0815781D0
(en)
|
2008-08-29 |
2008-10-08 |
Xention Ltd |
Novel potassium channel blockers
|
GB0815784D0
(en)
|
2008-08-29 |
2008-10-08 |
Xention Ltd |
Novel potassium channel blockers
|
GB0815782D0
(en)
|
2008-08-29 |
2008-10-08 |
Xention Ltd |
Novel potassium channel blockers
|
CA2741125A1
(en)
|
2008-10-22 |
2010-04-29 |
Merck Sharp & Dohme Corp. |
Novel cyclic benzimidazole derivatives useful anti-diabetic agents
|
AU2009308284B2
(en)
|
2008-10-23 |
2016-02-04 |
Vertex Pharmaceuticals, Incorporated |
Modulators of cystic fibrosis transmembrane conductance regulator
|
NZ592687A
(en)
|
2008-10-23 |
2013-04-26 |
Vertex Pharma |
Modulators of cystic fibrosis transmembrane conductance regulator
|
WO2010051206A1
(en)
|
2008-10-31 |
2010-05-06 |
Merck Sharp & Dohme Corp. |
Novel cyclic benzimidazole derivatives useful anti-diabetic agents
|
AU2009316802B2
(en)
|
2008-11-21 |
2015-02-26 |
Vtv Therapeutics Llc |
Adamantyl benzamide compounds
|
WO2010068601A1
(en)
|
2008-12-08 |
2010-06-17 |
Sanofi-Aventis |
A crystalline heteroaromatic fluoroglycoside hydrate, processes for making, methods of use and pharmaceutical compositions thereof
|
TW201028421A
(en)
*
|
2009-01-15 |
2010-08-01 |
Abbott Lab |
Novel benzenesulfonamides as calcium channel blockers
|
CN102365275B
(zh)
*
|
2009-01-28 |
2014-09-24 |
里格尔药品股份有限公司 |
羧酰胺化合物及其使用方法
|
GB0909672D0
(en)
|
2009-06-04 |
2009-07-22 |
Xention Discovery Ltd |
Compounds
|
ES2350077B1
(es)
|
2009-06-04 |
2011-11-04 |
Laboratorios Salvat, S.A. |
Compuestos inhibidores de 11beta-hidroxiesteroide deshidrogenasa de tipo 1.
|
GB0909671D0
(en)
|
2009-06-04 |
2009-07-22 |
Xention Discovery Ltd |
Compounds
|
CA2771278A1
(en)
|
2009-08-26 |
2011-03-03 |
Sanofi |
Novel crystalline heteroaromatic fluoroglycoside hydrates, pharmaceuticals comprising these compounds and their use
|
US8895596B2
(en)
|
2010-02-25 |
2014-11-25 |
Merck Sharp & Dohme Corp |
Cyclic benzimidazole derivatives useful as anti-diabetic agents
|
WO2011107494A1
(de)
|
2010-03-03 |
2011-09-09 |
Sanofi |
Neue aromatische glykosidderivate, diese verbindungen enthaltende arzneimittel und deren verwendung
|
EP2582709B1
(de)
|
2010-06-18 |
2018-01-24 |
Sanofi |
Azolopyridin-3-on-derivate als inhibitoren von lipasen und phospholipasen
|
US8530413B2
(en)
|
2010-06-21 |
2013-09-10 |
Sanofi |
Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments
|
TW201215387A
(en)
|
2010-07-05 |
2012-04-16 |
Sanofi Aventis |
Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament
|
TW201221505A
(en)
|
2010-07-05 |
2012-06-01 |
Sanofi Sa |
Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament
|
TW201215388A
(en)
|
2010-07-05 |
2012-04-16 |
Sanofi Sa |
(2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments
|
US8513430B2
(en)
|
2010-07-27 |
2013-08-20 |
High Point Pharmaceuticals, Llc |
Substituted thiazol-2-ylamine derivatives, pharmaceutical compositions, and methods of use as 11-beta HSD1 modulators
|
EP2677869B1
(en)
|
2011-02-25 |
2017-11-08 |
Merck Sharp & Dohme Corp. |
Novel cyclic azabenzimidazole derivatives useful as anti-diabetic agents
|
EP2683699B1
(de)
|
2011-03-08 |
2015-06-24 |
Sanofi |
Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
|
US8809325B2
(en)
|
2011-03-08 |
2014-08-19 |
Sanofi |
Benzyl-oxathiazine derivatives substituted with adamantane and noradamantane, medicaments containing said compounds and use thereof
|
US8828994B2
(en)
|
2011-03-08 |
2014-09-09 |
Sanofi |
Di- and tri-substituted oxathiazine derivatives, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof
|
WO2012120058A1
(de)
|
2011-03-08 |
2012-09-13 |
Sanofi |
Mit benzyl- oder heteromethylengruppen substituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
|
WO2012120057A1
(de)
|
2011-03-08 |
2012-09-13 |
Sanofi |
Neue substituierte phenyl-oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung
|
WO2012120053A1
(de)
|
2011-03-08 |
2012-09-13 |
Sanofi |
Verzweigte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
|
US8871758B2
(en)
|
2011-03-08 |
2014-10-28 |
Sanofi |
Tetrasubstituted oxathiazine derivatives, method for producing them, their use as medicine and drug containing said derivatives and the use thereof
|
US8809324B2
(en)
|
2011-03-08 |
2014-08-19 |
Sanofi |
Substituted phenyl-oxathiazine derivatives, method for producing them, drugs containing said compounds and the use thereof
|
WO2012120052A1
(de)
|
2011-03-08 |
2012-09-13 |
Sanofi |
Mit carbozyklen oder heterozyklen substituierte oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung
|
TW201300358A
(zh)
*
|
2011-03-14 |
2013-01-01 |
大正製藥股份有限公司 |
含氮縮合雜環化合物
|
KR101332805B1
(ko)
|
2011-03-31 |
2013-11-27 |
한국화학연구원 |
아다만틸기를 갖는 설파마이드 유도체 및 이의 약제학적으로 허용 가능한 염
|
WO2013037390A1
(en)
|
2011-09-12 |
2013-03-21 |
Sanofi |
6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
|
EP2760862B1
(en)
|
2011-09-27 |
2015-10-21 |
Sanofi |
6-(4-hydroxy-phenyl)-3-alkyl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
|
TWI622578B
(zh)
*
|
2011-12-21 |
2018-05-01 |
諾維拉治療公司 |
B型肝炎抗病毒劑
|
CA2868713A1
(en)
|
2012-03-29 |
2013-10-03 |
Takeda Pharmaceutical Company Limited |
Aromatic ring compound
|
AU2013296470B2
(en)
|
2012-08-02 |
2016-03-17 |
Merck Sharp & Dohme Corp. |
Antidiabetic tricyclic compounds
|
AU2014219020A1
(en)
|
2013-02-22 |
2015-07-23 |
Merck Sharp & Dohme Corp. |
Antidiabetic bicyclic compounds
|
WO2014139388A1
(en)
|
2013-03-14 |
2014-09-18 |
Merck Sharp & Dohme Corp. |
Novel indole derivatives useful as anti-diabetic agents
|
WO2015051496A1
(en)
|
2013-10-08 |
2015-04-16 |
Merck Sharp & Dohme Corp. |
Antidiabetic tricyclic compounds
|
KR20160070162A
(ko)
*
|
2013-11-05 |
2016-06-17 |
에프. 호프만-라 로슈 아게 |
자가면역 질병의 치료를 위한 RORc 조절인자로서 5,6,7,8-테트라하이드로-5,8-메타노신놀린 유도체
|
PT3074011T
(pt)
|
2013-11-25 |
2019-09-17 |
Corcept Therapeutics Inc |
Moduladores de receptores de glicocorticoides de azadecalina fundidas com octa-hidro
|
SG11201606080SA
(en)
|
2014-02-03 |
2016-08-30 |
Vitae Pharmaceuticals Inc |
Dihydropyrrolopyridine inhibitors of ror-gamma
|
US9255096B1
(en)
|
2014-10-07 |
2016-02-09 |
Allergan, Inc. |
Substituted 1,2,3,4-tetrahydrobenzo[C][2,7] naphthyridines and derivatives thereof as kinase inhibitors
|
HUE042335T2
(hu)
|
2014-10-14 |
2019-06-28 |
Vitae Pharmaceuticals Inc |
ROR-gamma dihidropirrolopiridin inhibitorai
|
US9663515B2
(en)
|
2014-11-05 |
2017-05-30 |
Vitae Pharmaceuticals, Inc. |
Dihydropyrrolopyridine inhibitors of ROR-gamma
|
US9845308B2
(en)
|
2014-11-05 |
2017-12-19 |
Vitae Pharmaceuticals, Inc. |
Isoindoline inhibitors of ROR-gamma
|
GB2532990A
(en)
|
2014-12-05 |
2016-06-08 |
Schlumberger Holdings |
Corrosion inhibition
|
WO2016095205A1
(en)
*
|
2014-12-19 |
2016-06-23 |
Merck Sharp & Dohme Corp. |
Heteroaryl orexin receptor antagonists
|
EP3331876B1
(en)
|
2015-08-05 |
2020-10-07 |
Vitae Pharmaceuticals, LLC |
Modulators of ror-gamma
|
GB2543498A
(en)
|
2015-10-19 |
2017-04-26 |
Schlumberger Holdings |
Corrosion inhibition
|
EP3377482B1
(en)
|
2015-11-20 |
2021-05-12 |
Vitae Pharmaceuticals, LLC |
Modulators of ror-gamma
|
TWI757266B
(zh)
|
2016-01-29 |
2022-03-11 |
美商維它藥物有限責任公司 |
ROR-γ調節劑
|
US9481674B1
(en)
|
2016-06-10 |
2016-11-01 |
Vitae Pharmaceuticals, Inc. |
Dihydropyrrolopyridine inhibitors of ROR-gamma
|
EP3474835B1
(en)
|
2016-06-23 |
2023-07-05 |
University of Maryland, Baltimore |
Non-catalytic substrate-selective p38 -specific mapk inhibitors with endothelial-stabilizing and anti-inflammatory activity, and methods of use thereof
|
EP3551176A4
(en)
|
2016-12-06 |
2020-06-24 |
Merck Sharp & Dohme Corp. |
ANTIDIABETIC HETEROCYCLIC COMPOUNDS
|
EP3558298A4
(en)
|
2016-12-20 |
2020-08-05 |
Merck Sharp & Dohme Corp. |
ANTIDIABETIC SPIROCHROMAN COMPOUNDS
|
EP3559005A1
(en)
|
2016-12-21 |
2019-10-30 |
Biotheryx Inc. |
Thienopyrrole derivatives for use in targeting proteins, compositions, methods, and uses thereof
|
WO2019018975A1
(en)
|
2017-07-24 |
2019-01-31 |
Vitae Pharmaceuticals, Inc. |
INHIBITORS OF ROR GAMMA
|
MX2020000887A
(es)
|
2017-07-24 |
2020-07-22 |
Vitae Pharmaceuticals Llc |
Inhibidores de ror?.
|
MX2021006731A
(es)
|
2018-12-07 |
2021-09-23 |
Univ Maryland |
Inhibidores de proteínas quinasas activadas por mitógeno p38 en sitio no atp/catalítico.
|
US11389432B2
(en)
|
2018-12-19 |
2022-07-19 |
Corcept Therapeutics Incorporated |
Methods of treating cancer comprising administration of a glucocorticoid receptor modulator and a cancer chemotherapy agent
|
US11234971B2
(en)
|
2018-12-19 |
2022-02-01 |
Corcept Therapeutics Incorporated |
Methods of treating cancer comprising administration of a glucocorticoid receptor modulator and a cancer chemotherapy agent
|
CA3131263C
(en)
|
2019-02-22 |
2024-01-02 |
Corcept Therapeutics Incorporated |
Therapeutic uses of relacorilant, a heteroaryl-ketone fused azadecalin glucocorticoid receptor modulator
|
CN114929229A
(zh)
|
2019-12-11 |
2022-08-19 |
科赛普特治疗学股份有限公司 |
用米立可兰治疗抗精神病药导致的体重增加的方法
|
US20230133132A1
(en)
*
|
2020-02-07 |
2023-05-04 |
Cytokinetics, Inc. |
Nampt modulators
|
AU2021274475B2
(en)
|
2020-05-18 |
2024-03-21 |
Gen1E Lifesciences Inc. |
P38alpha mitogen-activated protein kinase inhibitors
|
WO2022093610A1
(en)
|
2020-10-29 |
2022-05-05 |
Gen1E Lifesciences Inc. |
Crystalline 5-(dimethylamino)-n-(4-(morpholinomethyl)phenyl) naphthalene-1-sulfonmide di-hydrochloride di-hydrate
|
CA3213095A1
(en)
|
2021-03-23 |
2022-09-29 |
Adam Galan |
Substituted naphthyl p38alpha mitogen-activated protein kinase inhibitors
|